Evidence map›Paper›PMID 34716231›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2021

Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.

Zhefu Que, Maria I Olivero-Acosta, Jingliang Zhang, Muriel Eaton, Anke M Tukker, Xiaoling Chen, Jiaxiang Wu, Junkai Xie, Tiange Xiao, Kyle Wettschurack and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Excitatory Dysfunction and Phenotypic Rescue in a Human Neuronal Model ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Distinct Synaptic Mechanisms DrivebioRxiv : the preprint server for biology · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Distinctive In Vitro Phenotypes in iPSC-Derived Neurons From Patients With Gain- and Loss-of-FunctionThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Zhefu QueDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
Maria I Olivero-AcostaDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
Jingliang ZhangDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.ORCID 0000-0002-2903-1287
Muriel EatonDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
Anke M TukkerPurdue Institute for Integrative Neuroscience, Purdue University, Beijing, China, 100191.
Xiaoling ChenDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
Jiaxiang WuDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
Junkai XieDepartment of Chemical Engineering, Purdue University, West Lafayette, IN 47907.
Tiange XiaoDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
Kyle WettschurackDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
Layan YunisDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
J Marshall ShaferDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.ORCID 0000-0001-7828-3539
James A SchaberPurdue Imaging Facility, Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907.
Jean-Christophe RochetDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
Aaron B BowmanPurdue Institute for Integrative Neuroscience, Purdue University, Beijing, China, 100191.
Chongli YuanDepartment of Chemical Engineering, Purdue University, West Lafayette, IN 47907.
Zhuo HuangDepartment of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China, 100191.
Chang-Deng HuDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
Darci J TraderDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907.
William C SkarnesCellular Engineering, The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032.
Yang YangDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907 yangyang@purdue.edu.ORCID 0000-0001-6417-3654
Purdue University West Lafayette · USJackson Laboratory · USPeking University · CN

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Role and targeting of PRMT5 in prostate cancerR01CA212403 · NCI · PURDUE UNIVERSITY · PI HUANG, JIAOTI, LI, CHENGLONG · 2017 to 2021
$3.0M
Manganese exposure susceptibility as a modifier of excitotoxicity in Alzheimer's DiseaseR01ES031401 · NIEHS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOWMAN, AARON B, HARRISON, FIONA EDITH · 2020 to 2024
$2.7M
Neuronal and Behavioral Deficits Associated with Scn2a Deficiency in Autism Spectrum DisorderR01NS117585 · NINDS · PURDUE UNIVERSITY · PI YANG, YANG · 2021 to 2025
$2.0M
Neuronal hyperexcitability and seizures in a Scn2a deficient mouse modelR01NS123154 · NINDS · PURDUE UNIVERSITY · PI YANG, YANG · 2021 to 2025
$1.9M
Monitoring and Manipulating the Activity of the Immunoproteasome with Small MoleculesR01AI150847 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI TRADER, DARCI J · 2020 to 2023
$1.9M
Role of endosulfine-alpha expression and phosphorylation in Parkinson's DiseaseR03NS108229 · NINDS · PURDUE UNIVERSITY · PI ROCHET, JEAN-CHRISTOPHE · 2020 to 2021
$220k
NCATS NIH HHS UL1 TR002529NCI NIH HHS R01 CA212403NIAID NIH HHS R01 AI150847NIEHS NIH HHS R01 ES031401NINDS NIH HHS R01 NS117585NINDS NIH HHS R01 NS123154NINDS NIH HHS R03 NS108229
6 · The paper itself

Abstract

With the wide adoption of genomic sequencing in children having seizures, an increasing number of

Indexed as

Cerebral CortexEpilepsyGene EditingHumansInduced Pluripotent Stem CellsMutationNAV1.2 Voltage-Gated Sodium ChannelNeuronsNAV1.2 Voltage-Gated Sodium ChannelSCN2A protein, humananticonvulsantepilepsyhiPSCsL1342PSCN2Avoltage-gated sodium channel

Identifiers

PMID34716231
PMCPMC8660047
OpenAlexW3208929927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.